Online citations, reference lists, and bibliographies.

Calcium Supplement And Bone Medication Use In A US Medicare Health Maintenance Organization

B. Dawson-Hughes, Suzanne Harris, Gerard E. Dallal, Lancaster, Qi Zhou
Published 2002 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract: This study was conducted to determine the prevalence of the use of calcium supplements and of prescription medications to prevent or treat osteoporosis in men and women in a large New England Medicare Health Maintenance Organization (HMO). A two-page diet, medication use and medical history questionnaire was sent to a random sample of 9000 out of 82 985 members and 2932 (32.6%) responded. Over 97% of the participants were Caucasian and 64.7% were female. The mean ages of the men and women were 74.4 ± 5.8 and 74.6 ± 6.2 years, respectively. Sixty-nine percent of the men and 59% of the women consumed two or fewer servings of dairy foods per day. Calcium supplement use was more prevalent among the women than the men (66.8% vs 24.9%, p<0.001). Men and women with higher dairy food intakes were more likely to take calcium supplements than were those with lower dairy intakes. Prescription bone medications (including bisphosphonates, raloxifene and calcitonin) were used currently by 17.5% of the women and 2.3% of the men (p<0.001). An additional 16.2% of the women currently took estrogen. Among the women, bone medication use did not change with age but estrogen use declined with increasing age. Among women age 80+ years, 15.6% used bone medications and 4.9% took estrogen. According to a national survey, more than half the US Caucasian female population over age 80 years has bone density low enough to warrant treatment under current guidelines. Based on the results of this survey, many elderly men and women may benefit from increased utilization of calcium supplements and bone-active medications.
This paper references
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures study
CH IIIChesnut (2000)
10.1056/NEJM200102013440503
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.
M. Mcclung (2001)
10.1093/ajcn/67.1.18
Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis.
J. Nieves (1998)
10.1016/S0140-6736(96)07088-2
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
D. Black (1996)
10.1111/j.1753-4887.1990.tb02922.x
Use of vitamin and mineral supplements in the United States.
Insun Kim (1990)
EFFECT OF RISEDRONATE ON THE RISK OF HIP FRACTURE IN ELDERLY WOMEN EFFECT OF RISEDRONATE ON THE RISK OF HIP FRACTURE IN ELDERLY WOMEN
Aul (2001)
10.1016/S0002-9343(00)00490-3
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
C. Chesnut (2000)
10.1111/j.1532-5415.1990.tb05700.x
The necessity and safety of calcium and vitamin D in the elderly.
Risto Honkanen (1990)
Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Introduction.
(1998)
10.1056/NEJM199709043371003
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
B. Dawson-Hughes (1997)
10.1001/jama.282.14.1344
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
S. Harris (1999)
10.1093/jn/126.12.3001
Dietary intake of fat, fiber and other nutrients is related to the use of vitamin and mineral supplements in the United States: the 1992 National Health Interview Survey.
Mary Jane Slesinski (1996)
10.1136/bmj.308.6936.1081
Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women
M. Chapuy (1994)
The relationship between beliefs about nutrition and dietary practices of the elderly.
Wm. Alex Mcintosh (1990)
10.1002/jbmr.5650100517
Prevalence of low femoral bone density in older U.S. women from NHANES III.
A. Looker (1995)
10.1093/jn/124.suppl_8.1426S
Consumption of calcium in the U.S.: food sources and intake levels.
K. H. Fleming (1994)
10.1016/B978-012528640-4/50018-6
Risk Factors for Low Bone Mass in Men
T. V. Nguyen (1999)
10.1080/01621459.1996.10476712
A Semiparametric Transformation Approach to Estimating Usual Daily Intake Distributions
S. Nusser (1992)
Risk factors for low bone mass in men. In: Orwoll ES, editor. The effects of gender on skeletal health: osteoporosis in men
TV Nguyen (1999)
10.1080/07315724.1988.10720228
Nutrient supplement use by healthy elderly.
Stuart C. Hartz (1988)
10.1001/jama.285.3.320
Risk of new vertebral fracture in the year following a fracture.
R. Lindsay (2001)
10.1001/jama.282.7.637
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
B. Ettinger (1999)



This paper is referenced by
10.1097/01.TIN.0000285380.46959.23
Factors Influencing Dairy Product Consumption of Chinese Americans in Pennsylvania
Nan Lv (2007)
10.1097/01.mjt.0000132254.88027.71
Underutilization of Calcium and Vitamin D by Older Adults in a Large General Internal Medicine Practice
Jose Ness (2005)
10.1093/qjmed/hcl031
Calcium and vitamin D in the prevention of osteoporotic fractures.
Roger M. Francis (2006)
Hip Fracture Long-term Proton Pump Inhibitor Therapy and Risk of Correction
Y. Yang (2006)
10.1007/s00198-009-1034-7
The potential impact of new National Osteoporosis Foundation guidance on treatment patterns
B. Dawson-Hughes (2009)
10.1016/J.RHUM.2009.12.002
Apport de calcium et risque d’ostéoporose et de fractures chez les femmes françaises ☆
Patrice Fardellone (2010)
10.1016/j.jbspin.2009.08.007
Calcium intake and the risk of osteoporosis and fractures in French women.
Patrice Fardellone (2010)
10.1016/S0002-9343(03)00371-1
Strategies for the prevention of hip fracture.
M. Gourlay (2003)
10.1001/jama.296.24.2947
Long-term proton pump inhibitor therapy and risk of hip fracture.
Yu-Xiao Yang (2006)
10.1002/9781118704868.CH36
Sun, Nutrition, and the Mineralization of Bones and Teeth
Philippe Pierre Hujoel (2013)
10.1007/978-1-4471-2769-7_37
Blueberry in Calcium- and Vitamin D-Enriched Fermented Milk Is Able to Modulate Bone Metabolism in Postmenopausal Women
M. J. Davicco (2013)
10.1016/j.maturitas.2010.08.013
Older men's knowledge about osteoporosis and educational interventions to increase osteoporosis knowledge in older men: a systematic review.
Jean M. Gaines (2011)
10.17863/CAM.8420
Patterns and predictors of falls and their consequences in extreme old age
J. Fleming (2007)
10.1271/bbb.60219
Calcium from LactoCalciumTM Milk Mineral after Digestion with Pepsin Stimulates Mineralized Bone Nodule Formation in Human Osteoblast-Like SaOS-2 Cells in Vitro and May Be Rendered Bioavailable in Vivo
Leticia Gomez Rao (2007)
10.1002/jbmr.279
Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies.
H. Bischoff-Ferrari (2011)
10.1007/s00198-004-1668-4
Calcium supplement and osteoporosis medication use in women and men with recent fractures
A. Pro-Risquez (2004)
Semantic Scholar Logo Some data provided by SemanticScholar